Ask AI
ProCE Banner Activity

Optimizing Modern HAE Management With Novel Therapies and Patient-Centered Care (Marketing Campaign)

Clinical Thought

Learn how the treatment landscape for hereditary angioedema (HAE) is evolving as novel long-term prophylaxis therapies emerge, and attain take-home strategies to improve your practice in providing individualized care that optimizes treatment for patients with HAE.

Released: August 27, 2025

Share

Faculty Disclosure

Primary Author

Marc Riedl, MD, MS: researcher: Astria, Biocryst, Biomarin, CSL Behring, Intellia, Ionis, Kalvista, Pharvaris, Takeda; consultant/advisor/speaker: Astria, BioCryst, Biomarin, Celldex, CSL Behring, Cycle Pharma, Grifols, Intellia, Ionis, Kalvista, Novartis, Pharming, Pharvaris, Sanofi/Regeneron, Takeda.